Skip to main content

Biolife Solutions Inc

BLFS
Exchange
Nasdaq
Industry
Electromedical & Electrotherapeutic Apparatus
SEC CIK
0000834365

No open-market purchases or sales by Biolife Solutions Inc insiders were filed in the last 90 days; 216 institutions reported holding it in 13F filings for Q2 2026, worth $1.40B in total; no superinvestor holds it.

Q1 2024 vs. Q4 2023

How the institutions holding Biolife Solutions Inc changed between Q4 2023 and Q1 2024.

All holders in Q1 2024All holders in Q4 2023

13F holders of BLFS: Q4 2023 compared with Q1 2024
MeasureQ4 2023Q1 2024Change
Holders140149+9
Shares45.4M44.4M−981.9K (−2.2%)
Value$737.7M$823.5M+$85.8M (+11.6%)

New holders (18)

Institutions that held Biolife Solutions Inc at the end of Q1 2024 but not at the end of Q4 2023.

Sold out (9)

Institutions that held Biolife Solutions Inc at the end of Q4 2023 and filed for Q1 2024 without it.

Institutions that sold out of BLFS in Q1 2024
InstitutionShares, Q4 2023Value, Q4 2023
Millrace Asset Group, Inc.105,643$1.72M
Squarepoint Ops LLC52,980$860.9K
Jennison Associates LLC39,978$649.6K
Mesirow Financial Investment Management, Inc.26,710$459.3K
Landscape Capital Management, L.L.C.18,629$302.7K
Campbell & CO Investment Adviser LLC14,680$238.6K
Susquehanna International Group, LLP12,044$195.7K
Entropy Technologies, LP11,123$180.7K
Smartleaf Asset Management LLC154$2.57K